Clinical trial
Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect…
NCT00186836 · St. Joseph's Health Care London, Other · Completed
Key facts
| NCT number | NCT00186836 |
|---|---|
| Title | Efficacy Study of Combined Hepatitis A and Hepatitis B Vaccine to Protect Against Hepatitis B in Hemodialysis Patients |
| Official title | Efficacy of Combined Hepatitis A and Hepatitis B (Twinrix) Vaccine Compared With Hepatitis B Vaccine Alone in Providing Seroprotection Against Hepatitis B in Hemodialysis Patients |
| Lead sponsor | St. Joseph's Health Care London, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis B |
| Intervention type | Biological |
| Interventions | Engerix-B and Twinrix |
| Enrollment | 200 |
| Start date | Nov 1, 2004 |
| Completion | Nov 1, 2006 |
| First posted | Sep 16, 2005 |
| Last update posted | Apr 20, 2007 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: